WELCOME OFFER — 10% OFF YOUR FIRST ORDER · CODE LAUNCH10 · GET IT BY EMAIL

Ingredient knowledge · Compounds

Soya Isoflavones

Naturally occurring legume compounds · declared at a stated 20 mg

All articles checked for accuracy against the GB NHC Register and all sources have citations with verified links to their relevant studies.

Soya isoflavones are plant compounds found mainly in soybeans. They attract scientific interest because their structure allows weak interaction with oestrogen receptors, yet regulators have not authorised health claims for them.

This article explains what soya isoflavones are, summarises the research landscape and regulatory position, and states how WellsparQ declares them in product labelling. It also outlines safety considerations and why the brand presents a modest, clearly labelled amount.

Ingredient Snapshot

Soya Isoflavones ingredient
What it is
Plant-derived polyphenol compounds found in soybeans.
Where from
Soybean (Glycine max) and other legumes.
Known for
Phytoestrogenic isoflavones such as genistein, daidzein and glycitein, declared here at 20 mg.
In WellsparQ
  • Red Clover Blend20 mg (equivalent from extract)

Soya isoflavones are among the most researched — and most debated — plant compounds in nutrition. They are the reason soy has been studied for decades in connection with women's health and hormones. WellsparQ includes them as a small, declared amount and treats the topic with the care it deserves: the science is genuinely interesting, the regulatory position is clear, and neither should be overstated. This piece sets out what they are and how the rules frame them.

What isoflavones are

Isoflavones are a class of polyphenols found most abundantly in legumes, and especially in the soybean (Glycine max). The principal soya isoflavones are genistein, daidzein and glycitein, which occur in the bean mostly as sugar-bound glycosides (genistin, daidzin) and are released to their active forms during digestion or fermentation ¹².

Their scientific interest comes from structure: isoflavones are phytooestrogens — plant molecules whose shape lets them interact weakly with the body's oestrogen receptors, which is why they have been studied in the context of the menopause and hormone-related tissues ¹²³. One further wrinkle is individual variation: some people carry gut bacteria that convert daidzein into a compound called equol, and "equol producers" may respond differently — a reminder that isoflavone biology is not uniform across people ².

IsoflavoneGlycoside formNote
GenisteinGenistinMost abundant in soy ¹
DaidzeinDaidzinPrecursor of equol in some people ²
GlyciteinGlycitinPresent in smaller amounts

The research picture — reported as evidence

Isoflavones have a large and mixed literature. A 2025 systematic review and meta-analysis in Advances in Nutrition examined their effects on measures of estrogenicity in randomised trials ²; a 2025 review in PeerJ looked at menopausal symptoms in perimenopausal women ³; and a 2022 meta-analysis in In Vivo addressed the much-discussed question of breast cancer risk ¹. The findings across this field are nuanced and not uniformly positive — which is precisely why European regulators have not authorised any health claim for soya isoflavones. EFSA assessed proposed claims (for example around menopausal symptoms and bone) and did not find the evidence sufficient to support them ⁴. That is the honest summary: an actively studied compound, without an authorised benefit claim.

How WellsparQ uses it

Soya isoflavones appear as a single, declared inclusion.

WellsparQ productDeclared soya isoflavonesFactsheet note
Red Clover Blend20 mg (equivalent from extract)"Naturally occurring compounds from the legume family, at a stated 20 mg"

Source: WellsparQ Supplements Database. The amount is small and disclosed to the milligram rather than folded into a proprietary total. The formula is plant-based and suitable for vegetarians and vegans.

Safety and who should take care

Isoflavones are consumed routinely in soy-based diets. For a supplement, the sensible cautions are:

  • Hormone-sensitive conditions. Because isoflavones interact weakly with oestrogen receptors, anyone with a history of hormone-sensitive cancer (such as breast cancer), or taking hormone therapy or tamoxifen, should speak to their doctor before using an isoflavone supplement.
  • Pregnancy and breastfeeding. Best avoided as a concentrated supplement unless advised otherwise.
  • Soy allergy. Isoflavone extracts derive from soy — an allergen that must be declared.

Take as directed, and check with a GP or pharmacist if any of the above applies.

References

  1. Soy Isoflavones and Breast Cancer Risk: A Meta-analysis. In Vivo 2022. PMID 35241506. ↩ Back to text
  2. Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Advances in Nutrition 2025. PMID 39433088. ↩ Back to text
  3. Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis. PeerJ 2025. PMID 40718787. ↩ Back to text
  4. European Food Safety Authority (EFSA) — scientific opinions on isoflavone health claims (Article 13/14), and on the safety of isoflavones from food supplements for peri-/post-menopausal women. EFSA Journal. ↩ Back to text
  5. GB/EU Register of nutrition and health claims — no authorised claim for soya isoflavones; botanical claims on hold. ec.europa.eu food-feed-portal.
General information only — not medical advice. Food supplements should not be used as a substitute for a varied diet and a healthy lifestyle. Do not exceed the stated recommended daily dose. Keep out of reach of young children. If you are pregnant, breastfeeding, or taking medication, speak to your GP or pharmacist before starting a new supplement.
Shopping Basket